Hubert Pellegrin SA
Hubert Pellegrin reported total assets of 623,769 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Aug 2026).
The score of Hubert Pellegrin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +74 % Total assets -13 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hubert Pellegrin's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Aug 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 09 Mar 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
Hubert Pellegrin's financial analysis
- Solvency19.8%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hubert Pellegrin
Hubert Pellegrin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0406.446.826
- VAT number
- BE0406446826
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 01 Jan 1969
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 24 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Hubert Pellegrin (SA) has been based in Uccle since 1969, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 1,799 € and equity of 123,634 €; its revenue is not published. Its solvency stands at 19.8%, below the median of its sector (37.8%).
Companies similar to Hubert Pellegrin
Companies in the same business, of comparable size and area, outside its group.
- Bioclin Retail sale of pharmaceutical products Ostend · balance sheet 623,434 €
- Pharmacie Gurné Retail sale of pharmaceutical products Flémalle · balance sheet 624,135 €
- Apotheek Denys Retail sale of pharmaceutical products Ghent · balance sheet 625,086 €
- Zichem Pharma Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet 622,406 €
- MVA Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 621,644 €
- Heldo Retail sale of pharmaceutical products Erpe-Mere · balance sheet 621,357 €
- Pharmovan Retail sale of pharmaceutical products Leuven · balance sheet 626,313 €
- Pharmadil Retail sale of pharmaceutical products Dilbeek · balance sheet 620,651 €
Frequently asked questions about Hubert Pellegrin
What is the revenue of Hubert Pellegrin?
Hubert Pellegrin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hubert Pellegrin?
In Belgium, the VAT number is the company number prefixed with BE: BE0406446826 for Hubert Pellegrin, if the company is VAT-registered. Its company number (CBE) is 0406.446.826.
Where is the registered office of Hubert Pellegrin?
According to the CBE register, the registered office of Hubert Pellegrin is in 1180 Uccle.
What is the equity of Hubert Pellegrin?
At the close of the 2025 financial year, the equity of Hubert Pellegrin amounts to 123,634 €, a solvency of 19.8% of total assets.
Who manages Hubert Pellegrin?
The register lists 6 active mandates at Hubert Pellegrin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hubert Pellegrin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →